Edward Rebar
Vice President, Technology
Pharmaceutical
Sangamo Therapeutics
United States of America
Biography
Edward Rebar, Ph.D., has served as Vice President, Technology since 2008, a capacity in which he directs the lead design and optimization for our therapeutic programs. Since joining Sangamo in 1998, Dr. Rebar has held several leadership positions at the company, including Senior Director, Technology, in which he led the development of Sangamo’s zinc finger protein design platform and co-managed the Company’s partnership with Sigma Aldrich. Dr. Rebar has authored over 55 publications relating to the development of customized DNA binding proteins and nucleases for genome editing, as well as numerous patents. Prior to joining Sangamo, he was a post-doctoral fellow at the University of California, Berkeley. Dr. Rebar earned his B.S. in Biochemistry from Rutgers University and his Ph.D. in Biophysics and Structural Biology from MIT.
Research Interest
Biotechnology ,Bio Pharmaceutics Pharmakinetics ,Clinical Pharmacy,Pharmaceutical Microbiology
